Literature DB >> 26941287

The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women.

Sung Jin Huh1, Hannah Oh2, Michael A Peterson3, Vanessa Almendro1, Rong Hu4, Michaela Bowden3, Rosina L Lis3, Maura B Cotter3, Massimo Loda3, William T Barry5, Kornelia Polyak6, Rulla M Tamimi7.   

Abstract

The frequency and proliferative activity of tissue-specific stem and progenitor cells are suggested to correlate with cancer risk. In this study, we investigated the association between breast cancer risk and the frequency of mammary epithelial cells expressing p27, estrogen receptor (ER), and Ki67 in normal breast tissue. We performed a nested case-control study of 302 women (69 breast cancer cases, 233 controls) who had been initially diagnosed with benign breast disease according to the Nurses' Health Studies. Immunofluorescence for p27, ER, and Ki67 was performed on tissue microarrays constructed from benign biopsies containing normal mammary epithelium and scored by computational image analysis. We found that the frequency of Ki67(+) cells was positively associated with breast cancer risk among premenopausal women [OR = 10.1, 95% confidence interval (CI) = 2.12-48.0]. Conversely, the frequency of ER(+) or p27(+) cells was inversely, but not significantly, associated with subsequent breast cancer risk (ER(+): OR = 0.70, 95% CI, 0.33-1.50; p27(+): OR = 0.89, 95% CI, 0.45-1.75). Notably, high Ki67(+)/low p27(+) and high Ki67(+)/low ER(+) cell frequencies were significantly associated with a 5-fold higher risk of breast cancer compared with low Ki67(+)/low p27(+) and low Ki67(+)/low ER(+) cell frequencies, respectively, among premenopausal women (Ki67(hi)/p27(lo): OR = 5.08, 95% CI, 1.43-18.1; Ki67(hi)/ER(lo): OR = 4.68, 95% CI, 1.63-13.5). Taken together, our data suggest that the fraction of actively cycling cells in normal breast tissue may represent a marker for breast cancer risk assessment, which may therefore impact the frequency of screening procedures in at-risk women. Cancer Res; 76(7); 1926-34. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 26941287      PMCID: PMC4873436          DOI: 10.1158/0008-5472.CAN-15-1927

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

Review 1.  Proliferation marker Ki-67 in early breast cancer.

Authors:  Ander Urruticoechea; Ian E Smith; Mitch Dowsett
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

Review 2.  Mammary gland development: cell fate specification, stem cells and the microenvironment.

Authors:  Jamie L Inman; Claire Robertson; Joni D Mott; Mina J Bissell
Journal:  Development       Date:  2015-03-15       Impact factor: 6.868

3.  Atypical hyperplastic lesions of the female breast. A long-term follow-up study.

Authors:  D L Page; W D Dupont; L W Rogers; M S Rados
Journal:  Cancer       Date:  1985-06-01       Impact factor: 6.860

4.  Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells.

Authors:  J H van Dierendonck; R Keijzer; C J van de Velde; C J Cornelisse
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

Review 5.  Molecular and biologic markers of premalignant lesions of human breast.

Authors:  Savitri Krishnamurthy; Nour Sneige
Journal:  Adv Anat Pathol       Date:  2002-05       Impact factor: 3.875

6.  Estrogen and progesterone receptors in the normal female breast.

Authors:  D Ricketts; L Turnbull; G Ryall; R Bakhshi; N S Rawson; J C Gazet; C Nolan; R C Coombes
Journal:  Cancer Res       Date:  1991-04-01       Impact factor: 12.701

7.  Cell proliferation, apoptosis, and expression of Bcl-2 and Bax in non-lactating human breast epithelium in relation to the menstrual cycle and reproductive history.

Authors:  F Feuerhake; W Sigg; E A Höfter; P Unterberger; U Welsch
Journal:  Breast Cancer Res Treat       Date:  2003-01       Impact factor: 4.872

8.  Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

Authors:  K Polyak; M H Lee; H Erdjument-Bromage; A Koff; J M Roberts; P Tempst; J Massagué
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

9.  Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

Authors:  H Kiyokawa; R D Kineman; K O Manova-Todorova; V C Soares; E S Hoffman; M Ono; D Khanam; A C Hayday; L A Frohman; A Koff
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

10.  Risk factors for breast cancer according to estrogen and progesterone receptor status.

Authors:  Graham A Colditz; Bernard A Rosner; Wendy Y Chen; Michelle D Holmes; Susan E Hankinson
Journal:  J Natl Cancer Inst       Date:  2004-02-04       Impact factor: 13.506

View more
  24 in total

1.  Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.

Authors:  Carol J Fabian; Lauren Nye; Kandy R Powers; Jennifer L Nydegger; Amy L Kreutzjans; Teresa A Phillips; Trina Metheny; Onalisa Winblad; Carola M Zalles; Christy R Hagan; Merit L Goodman; Byron J Gajewski; Devin C Koestler; Prabhakar Chalise; Bruce F Kimler
Journal:  Cancer Prev Res (Phila)       Date:  2019-08-16

2.  Mathematical Modeling Links Pregnancy-Associated Changes and Breast Cancer Risk.

Authors:  Daniel Temko; Yu-Kang Cheng; Kornelia Polyak; Franziska Michor
Journal:  Cancer Res       Date:  2017-03-30       Impact factor: 12.701

3.  Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses' Health Study.

Authors:  Megan A Healey; Kelly A Hirko; Andrew H Beck; Laura C Collins; Stuart J Schnitt; A Heather Eliassen; Michelle D Holmes; Rulla M Tamimi; Aditi Hazra
Journal:  Breast Cancer Res Treat       Date:  2017-08-08       Impact factor: 4.872

4.  Immunohistochemistry scoring of breast tumor tissue microarrays: A comparison study across three software applications.

Authors:  Gabrielle M Baker; Vanessa C Bret-Mounet; Tengteng Wang; Mitko Veta; Hanqiao Zheng; Laura C Collins; A Heather Eliassen; Rulla M Tamimi; Yujing J Heng
Journal:  J Pathol Inform       Date:  2022-06-28

5.  Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics With Invasive Breast Cancer Risk.

Authors:  Mustapha Abubakar; Shaoqi Fan; Erin Aiello Bowles; Lea Widemann; Máire A Duggan; Ruth M Pfeiffer; Roni T Falk; Scott Lawrence; Kathryn Richert-Boe; Andrew G Glass; Teresa M Kimes; Jonine D Figueroa; Thomas E Rohan; Gretchen L Gierach
Journal:  JNCI Cancer Spectr       Date:  2021-02-06

Review 6.  Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk.

Authors:  Vahid Atashgaran; Joseph Wrin; Simon Charles Barry; Pallave Dasari; Wendy V Ingman
Journal:  Front Oncol       Date:  2016-12-26       Impact factor: 6.244

7.  The origins of breast cancer associated with mammographic density: a testable biological hypothesis.

Authors:  Norman Boyd; Hal Berman; Jie Zhu; Lisa J Martin; Martin J Yaffe; Sofia Chavez; Greg Stanisz; Greg Hislop; Anna M Chiarelli; Salomon Minkin; Andrew D Paterson
Journal:  Breast Cancer Res       Date:  2018-03-07       Impact factor: 6.466

8.  Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study.

Authors:  Margarita Posso; Josep M Corominas; Laia Serrano; Marta Román; Isabel Torá-Rocamora; Laia Domingo; Anabel Romero; María Jesús Quintana; María Vernet-Tomas; Marisa Baré; Carmen Vidal; Mar Sánchez; Francina Saladié; Carmen Natal; Joana Ferrer; Sònia Servitja; María Sala; Xavier Castells
Journal:  Cancer Med       Date:  2017-05-04       Impact factor: 4.452

9.  Prenatal polycyclic aromatic hydrocarbons, altered ERα pathway-related methylation and expression, and mammary epithelial cell proliferation in offspring and grandoffspring adult mice.

Authors:  Debashish Sahay; Susan E Lloyd; Janelle A Rivera; Jacqueline Jezioro; Jacob D McDonald; Masha Pitiranggon; Beizhan Yan; Matthias Szabolcs; Mary Beth Terry; Rachel L Miller
Journal:  Environ Res       Date:  2021-03-04       Impact factor: 6.498

10.  Hormone Receptor Expression Variations in Normal Breast Tissue: Preliminary Results of a Prospective Observational Study.

Authors:  Giacomo Santandrea; Chiara Bellarosa; Dino Gibertoni; Maria C Cucchi; Alejandro M Sanchez; Gianluca Franceschini; Riccardo Masetti; Maria P Foschini
Journal:  J Pers Med       Date:  2021-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.